Sumitomo Mitsui Trust Holdings, Inc. Gilead Sciences, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$134 Billion
Q2 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,968,143 shares of GILD stock, worth $248 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,968,143

Previous 3,484,702 14.82%

Holding current value

$248 Million

Previous $255 Million 20.22%

% of portfolio

0.15%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $32.6 Million - $37.6 Million	-516,559 Reduced 14.82%	2,968,143 $204 Million
Q1 2024 Apr 19, 2024	BUY	$71.58 - $87.29 $731,404 - $891,929	10,218 Added 0.29%	3,484,702 $255 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $4.22 Million - $4.78 Million	57,537 Added 1.68%	3,474,484 $281 Million
Q3 2023 Oct 30, 2023	SELL	$73.94 - $80.67 $2.73 Million - $2.98 Million	-36,950 Reduced 1.07%	3,416,947 $256 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $33.1 Million - $37.7 Million	-434,927 Reduced 11.18%	3,453,897 $266 Million
Q1 2023 Apr 27, 2023	SELL	$77.31 - $88.08 $28 Million - $31.9 Million	-362,712 Reduced 8.53%	3,888,824 $323 Million
Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $15.3 Million - $21.9 Million	-245,057 Reduced 5.45%	4,251,536 $365 Million
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $957,343 - $1.09 Million	16,079 Added 0.36%	4,496,593 $277 Million
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $1.99 Million - $2.24 Million	-34,519 Reduced 0.76%	4,480,514 $277 Million
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $481,083 - $602,849	-8,306 Reduced 0.18%	4,515,033 $268 Million
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $37.9 Million - $43 Million	583,717 Added 14.82%	4,523,339 $328 Million
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $13.3 Million - $14.3 Million	-195,808 Reduced 4.73%	3,939,622 $275 Million
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $43.2 Million - $47.3 Million	-681,373 Reduced 14.15%	4,135,430 $285 Million
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $14.7 Million - $16.8 Million	-245,343 Reduced 4.85%	4,816,803 $311 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $35.9 Million - $40.9 Million	-633,599 Reduced 11.12%	5,062,146 $295 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $2.67 Million - $3.36 Million	-43,074 Reduced 0.75%	5,695,745 $360 Million
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $34.3 Million - $39.8 Million	473,677 Added 9.0%	5,738,819 $442 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $2.06 Million - $2.63 Million	32,841 Added 0.63%	5,265,142 $394 Million
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $4.75 Million - $5.22 Million	77,087 Added 1.5%	5,232,301 $340 Million
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $3.43 Million - $3.79 Million	54,910 Added 1.08%	5,155,214 $327 Million
Q2 2019 Jul 29, 2019	SELL	$61.87 - $69.38 $7.02 Million - $7.87 Million	-113,456 Reduced 2.18%	5,100,304 $345 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $10.5 Million - $11.7 Million	167,292 Added 3.32%	5,213,760 $339 Million
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $48.4 Million - $63.2 Million	800,268 Added 18.85%	5,046,468 $312 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $4.89 Million - $5.41 Million	68,555 Added 1.64%	4,246,200 $328 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $17.9 Million - $20.9 Million	275,803 Added 7.07%	4,177,645 $296 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $4.12 Million - $5.02 Million	56,537 Added 1.47%	3,901,842 $294 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $5.29 Million - $6.21 Million	74,410 Added 1.97%	3,845,305 $275 Million
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $3.44 Million - $4.08 Million	-47,702 Reduced 1.25%	3,770,895 $306 Million
Q2 2017 Aug 07, 2017	BUY	N/A	3,818,597	3,818,597 $270 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Gilead Sciences, Inc. Transaction History